Mike Thompson, chief executive of the Association of the British Pharmaceutical Industry, discusses the challenges ahead for British life sciences. "We need calm heads and the industry is absolutely willing to work with the Government to make the case for investment, because in the past we offered a bridgehead to Europe, and this has now gone."